RecallDepth
Class III Terminated

mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial packaged in a carton, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-4685-01.

This recall has been terminated (originally issued August 3, 2016).

Company
Teva North America
Recall Initiated
May 31, 2016
Posted
August 3, 2016
Recall Number
D-1451-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,506 vials
Firm Location
Horsham, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.

Distribution

Nationwide

Lot / Code Info

Lot # 31318659B, Exp 02/17

More recalls by Teva North America

View all recalls by this company →

Other recent Class III Drug recalls